Mind Medicine MindMed (MNMD)
(Delayed Data from NSDQ)
$8.23 USD
+0.28 (3.52%)
Updated May 24, 2024 03:59 PM ET
After-Market: $8.23 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Income Statements
Fiscal Year end for Mind Medicine MindMed Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 94 | 66 | 94 | 33 | 11 |
Income After Depreciation & Amortization | -94 | -66 | -94 | -33 | -11 |
Non-Operating Income | -2 | 10 | 0 | -1 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -96 | -57 | -94 | -34 | -11 |
Income Taxes | 0 | 0 | -1 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -96 | -57 | -93 | -34 | -11 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -96 | -57 | -93 | -34 | -11 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -91 | -63 | -91 | -33 | -11 |
Depreciation & Amortization (Cash Flow) | 3 | 3 | 3 | 0 | 0 |
Income After Depreciation & Amortization | -94 | -66 | -94 | -33 | -11 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 39.16 | 30.86 | 27.39 | 24.09 | NA |
Diluted EPS Before Non-Recurring Items | -2.44 | -2.09 | -3.45 | -1.50 | NA |
Diluted Net EPS (GAAP) | -2.44 | -1.84 | -3.45 | -1.50 | NA |
Fiscal Year end for Mind Medicine MindMed Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 22.21 | 22.21 | 21.61 | 29.19 | 20.86 |
Income After SG&A, R&D, and Dept/Amort Expenses | -22.21 | -22.21 | -21.61 | -29.19 | -20.86 |
Non-Operating Income | -31.76 | -1.66 | 3.69 | 0.05 | -3.95 |
Interest Expense | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -54.40 | -23.86 | -17.92 | -29.13 | -24.82 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -54.40 | -23.86 | -17.92 | -29.13 | -24.82 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -54.40 | -23.86 | -17.92 | -29.13 | -24.82 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 47.86 | 40.45 | 39.72 | 38.58 | 38.08 |
Diluted EPS Before Non-Recurring Items | -0.60 | -0.59 | -0.53 | -0.72 | -0.51 |
Diluted Net EPS (GAAP) | -1.14 | -0.58 | -0.45 | -0.76 | -0.65 |